A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: The MED trial

Mary E.R. O'Brien, D. Watkins, C. Ryan, K. Priest, C. Corbishley, A. Norton, S. Ashley, N. Rowell, R. Sayer

Research output: Contribution to journal › Article › peer-review

106 Scopus citations

Fingerprint

Dive into the research topics of 'A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: The MED trial'. Together they form a unique fingerprint.

Medicine & Life Sciences